Advertisement

Ads Placeholder
Loading...

Raia Drogasil S.A.

RADLYPNK
Healthcare
Medical - Pharmaceuticals
$4.25
$-0.21(-4.71%)
U.S. Market opens in 53h 58m

Raia Drogasil S.A. (RADLY) Stock Overview

Explore Raia Drogasil S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap7.4B
P/E Ratio29.39
EPS (TTM)$0.15
ROE0.19%
Fundamental Analysis

AI Price Forecasts

1 Month$4.76
3 Months$6.10
1 Year Target$2.73

RADLY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Raia Drogasil S.A. (RADLY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 36.16, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.73.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 29.39 and a market capitalization of 7.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-4.71%
5-Day Change
-6.20%
1-Month Change
-9.79%
3-Month Change
6.49%
6-Month Change
16.41%
Year-to-Date (YTD) Change
6.49%
1-Year Change
17.70%
3-Year Change
-29.18%
5-Year Change
-3.87%
All-Time (Max) Change
10.65%

Contact Information

55 11 3769 5678
Av. Corifeu de Azevedo Marques, 3097, São Paulo, SP, 05.339-900

Company Facts

662,750 Employees
IPO DateJul 19, 2016
CountryBR
Actively Trading

Frequently Asked Questions